N/A
Completed N=8,476
Factors Contribute to Very Late Stent Thrombosis After New Generation DES Implantation in China
Stent Thrombosis
Source: ClinicalTrials.gov NCT03491891 ↗
Enrolled (actual)
8,476
Serious AEs
0.0%
Results posted
Sep 2019
Primary outcomePrimary: Very Late Stent Thrombosis — 92; 35 Participants
Summary
The investigators sought to identify and verify the potential correlates and mechanisms of Very Late Stent Thrombosis (VLST) after the implantation of new generation drug eluting steng in China from an analysis of multicenter registries.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Very Late Stent Thrombosis |
92; 35 | — |
Eligibility Criteria
Inclusion Criteria
- Patients>18y, admitted for acute coronary syndrome,successfully underwent PCI with at least one stent, sign informed consent.
Exclusion Criteria
- Expected lifetime was less than 1 year for any severe disease(such as tumor,severe respiratory failure et al). There is a surgical plan for important organs within 1 year after surgery and anti-platelet drugs should be discontinued. Refusing to sign informed consent.Died prior to discharge. Poor compliance, unable to participate in regular follow-up.
Data sourced from ClinicalTrials.gov (NCT03491891). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.